These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1764758)

  • 1. [Antivenom serotherapy: its applications, its limitations, its future].
    Chippaux JP; Goyffon M
    Bull Soc Pathol Exot; 1991; 84(3):286-97. PubMed ID: 1764758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of snake bite.
    Reid HA; Theakston RD
    Bull World Health Organ; 1983; 61(6):885-95. PubMed ID: 6609008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea.
    Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD
    Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antivenom therapy in Vipera palaestinae bites.
    Bentur Y; Raikhlin-Eisenkraft B; Galperin M
    Toxicon; 2004 Jul; 44(1):53-7. PubMed ID: 15225562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bite of a sea snake (Hydrophis spiralis): a case report from Sri Lanka.
    Amarasekera N; Jayawardena A; Ariyaratnam A; Hewage UC; de Silva A
    J Trop Med Hyg; 1994 Aug; 97(4):195-8. PubMed ID: 8064939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years.
    Yeung JM; Little M; Murray LM; Jelinek GA; Daly FF
    Med J Aust; 2004 Dec 6-20; 181(11-12):703-5. PubMed ID: 15588174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low-dose snake antivenom in severe neurotoxic snake envenoming.
    Singh A; Agarwal R
    Am J Emerg Med; 2008 Nov; 26(9):1058-9. PubMed ID: 19091272
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
    Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
    Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antivenom and skin necrosis after green pit viper bites.
    Chotenimitkhun R; Rojnuckarin P
    Clin Toxicol (Phila); 2008 Feb; 46(2):122-5. PubMed ID: 18259959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraspecific antivenins and exotic bites of snakes: about two case reports].
    de Rudnicki S; Debien B; Leclerc T; Clapson P; Merens A; Perez JP; Lenoir B
    Ann Fr Anesth Reanim; 2008 Apr; 27(4):326-9. PubMed ID: 18430541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
    Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viper bite with continuous defibrination despite adequate treatment with antivenom.
    Jacob J
    J Assoc Physicians India; 2006 Sep; 54():733-4. PubMed ID: 17212024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of antivenom in snake bite poisoning.
    Karunaratne KE; Anandadas JA
    Ceylon Med J; 1973 Mar; 18(1):37-43. PubMed ID: 4773540
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance.
    Visser LE; Kyei-Faried S; Belcher DW; Geelhoed DW; van Leeuwen JS; van Roosmalen J
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):445-50. PubMed ID: 18190937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antivenom for Bungarus candidus.
    Leeprasert W; Kaojarern S
    J Med Assoc Thai; 2007 Jul; 90(7):1467-76. PubMed ID: 17710993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases.
    Açikalin A; Gökel Y; Kuvandik G; Duru M; Köseoğlu Z; Satar S
    Am J Emerg Med; 2008 May; 26(4):402-7. PubMed ID: 18410806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin.
    Chippaux JP; Massougbodji A; Stock RP; Alagon A;
    Am J Trop Med Hyg; 2007 Sep; 77(3):538-46. PubMed ID: 17827375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premedication before antivenom therapy.
    Ford RM
    Med J Aust; 1992 Feb; 156(3):223. PubMed ID: 1622472
    [No Abstract]   [Full Text] [Related]  

  • 20. [Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom].
    de Haro L; Lang J; Bedry R; Guelon D; Harry P; Marchal-Mazet F; Jouglard J
    Ann Fr Anesth Reanim; 1998; 17(7):681-7. PubMed ID: 9750806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.